Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore James

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Expert Opinion on Pharmacotherapy|December 9, 2024
Doravirine/islatravir for the treatment of HIVValerie Williams, Theodore James Cory
Current HIV Research|December 28, 2021
The Importance of Tissue Sanctuaries and Cellular Reservoirs of HIV-1William Kalada, Theodore James Cory
Expert Opinion on Pharmacotherapy|June 23, 2021
An evaluation of ledipasvir + sofosbuvir for the treatment of chronic hepatitis C infectionPearson Balatow, Amber Sandlin, Theodore James Cory
Expert Opinion on Pharmacotherapy|September 20, 2022
An evaluation of long-acting cabotegravir + rilpivirine for the treatment of virologically suppressed adults living with HIVHamdi Qazzaz, Christopher Parganas, Theodore James Cory
Current Opinion in Gastroenterology|July 9, 2015
Pancreatic painRobert A Moran, Theodore James, Pankaj Jay Pasricha
Expert Opinion on Drug Metabolism & Toxicology|September 21, 2024
Drug-drug interactions in HIV-infected patients receiving chemotherapyChrystalyn Branch, Jan Parson-Martinez, Theodore James Cory
Neuroimmune Pharmacology and Therapeutics|December 19, 2022
Senescent macrophages alter fibroblast fibrogenesis in response to SARS-CoV-2 infectionBrandt Pence, Yufeng Zhang, Ivy Antwi, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 24, 2025
Clinical considerations on the use of antiretrovirals and renal impairmentChristopher Livesay, Kubwayo Kayihura Mike, Karissa Grey, et al.
Clinical Biochemistry|December 3, 2014
Use of biomarkers for the assessment of chemotherapy-induced cardiac toxicityEric S Christenson, Theodore James, Vineet Agrawal, et al.
Expert Opinion on Pharmacotherapy|January 2, 2024
Expanding therapeutic options: lenacapavir + bictegravir as a potential treatment for HIVJessica Doan, Shannon Brunzo-Hager, Brittany Satterly, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Expert Opinion on Pharmacotherapy|December 9, 2024
Doravirine/islatravir for the treatment of HIVValerie Williams, Theodore James Cory
Current HIV Research|December 28, 2021
The Importance of Tissue Sanctuaries and Cellular Reservoirs of HIV-1William Kalada, Theodore James Cory
Expert Opinion on Pharmacotherapy|June 23, 2021
An evaluation of ledipasvir + sofosbuvir for the treatment of chronic hepatitis C infectionPearson Balatow, Amber Sandlin, Theodore James Cory
Expert Opinion on Pharmacotherapy|September 20, 2022
An evaluation of long-acting cabotegravir + rilpivirine for the treatment of virologically suppressed adults living with HIVHamdi Qazzaz, Christopher Parganas, Theodore James Cory
Current Opinion in Gastroenterology|July 9, 2015
Pancreatic painRobert A Moran, Theodore James, Pankaj Jay Pasricha
Expert Opinion on Drug Metabolism & Toxicology|September 21, 2024
Drug-drug interactions in HIV-infected patients receiving chemotherapyChrystalyn Branch, Jan Parson-Martinez, Theodore James Cory
Neuroimmune Pharmacology and Therapeutics|December 19, 2022
Senescent macrophages alter fibroblast fibrogenesis in response to SARS-CoV-2 infectionBrandt Pence, Yufeng Zhang, Ivy Antwi, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 24, 2025
Clinical considerations on the use of antiretrovirals and renal impairmentChristopher Livesay, Kubwayo Kayihura Mike, Karissa Grey, et al.
Clinical Biochemistry|December 3, 2014
Use of biomarkers for the assessment of chemotherapy-induced cardiac toxicityEric S Christenson, Theodore James, Vineet Agrawal, et al.
Expert Opinion on Pharmacotherapy|January 2, 2024
Expanding therapeutic options: lenacapavir + bictegravir as a potential treatment for HIVJessica Doan, Shannon Brunzo-Hager, Brittany Satterly, et al.
Pageof 3